Correlation Between ZyVersa Therapeutics and Edgewise Therapeutics

Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and Edgewise Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and Edgewise Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ZyVersa Therapeutics and Edgewise Therapeutics, you can compare the effects of market volatilities on ZyVersa Therapeutics and Edgewise Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of Edgewise Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and Edgewise Therapeutics.

Diversification Opportunities for ZyVersa Therapeutics and Edgewise Therapeutics

0.23

Correlation Coefficient

ZyVersa Therapeutics  Edgewise Therapeutics

Modest diversification

The 3 months correlation between ZyVersa and Edgewise is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and Edgewise Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edgewise Therapeutics and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with Edgewise Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edgewise Therapeutics has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and Edgewise Therapeutics go up and down completely randomly.

Pair Corralation between ZyVersa Therapeutics and Edgewise Therapeutics

Given the investment horizon of 90 days ZyVersa Therapeutics is expected to under-perform the Edgewise Therapeutics. In addition to that, ZyVersa Therapeutics is 2.26 times more volatile than Edgewise Therapeutics. It trades about -0.07 of its total potential returns per unit of risk. Edgewise Therapeutics is currently generating about 0.01 per unit of volatility. If you would invest  2,849  in Edgewise Therapeutics on October 8, 2024 and sell it today you would lose (77.00) from holding Edgewise Therapeutics or give up 2.7% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

ZyVersa Therapeutics  vs.  Edgewise Therapeutics

ZyVersa Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ZyVersa Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Edgewise Therapeutics

Risk-Adjusted Performance

0 of 100

Weak

Over the last 90 days Edgewise Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Edgewise Therapeutics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with ZyVersa Therapeutics and Edgewise Therapeutics

The main advantage of trading using opposite ZyVersa Therapeutics and Edgewise Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, Edgewise Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edgewise Therapeutics will offset losses from the drop in Edgewise Therapeutics' long position.

The idea behind ZyVersa Therapeutics and Edgewise Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.